|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/20 | (2006.01) |
| A61K 31/439 | (2006.01) |
| (11) | Patento numeris | 2156824 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09014500.4 |
| Europos patento paraiškos padavimo data | 2005-03-24 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-02-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2012-10-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 556025 P | 2004-03-25 | US | |
| 638388 P | 2004-12-27 | US |
| (72) |
Sugihara, Akio, JP
Yasuji, Takehiko, JP
Masaki, Katsuhiro, JP
Murayama, Daisuke, JP
|
| (73) |
Astellas Pharma Inc.,
3-11, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo 103-8411,
JP
|
| (54) | Composition of solifenacin or salt thereof for use in solid formulation |
| Composition of solifenacin or salt thereof for use in solid formulation |